Every treatment we track, side by side. Same information, same order, every time.
durvalumab
Immunotherapy used across selected lung, biliary tract, liver, bladder and other contexts
pembrolizumab
Immunotherapy used across multiple cancers including lung, melanoma, bladder, head and neck, colorectal MSI-H/dMMR and others
nivolumab
Immunotherapy used across multiple cancers including lung, melanoma, kidney, bladder, esophageal and others
atezolizumab
Immunotherapy used across selected lung, liver, melanoma and other cancer contexts
ipilimumab
CTLA-4 immunotherapy commonly used in combination with nivolumab in selected cancers